Drugs as instruments: Describing and testing a behavioral approach to the study of neuroenhancement

Frontiers in Psychology

Volumn 7, Issue AUG, 2016, Pages

  Brand, Ralf ^a   Wolff, Wanja ^b   Ziegler, Matthias ^c  

^a UNIVERSITY OF POTSDAM   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cognitive enhancement; Drug instrumentalization; Non addictive behavior; Psychoactive drugs; User types

Indexed keywords

EID: 84988606161     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2016.01226     Document Type: Article

References (64)

1. Anderson, P., and Baumberg, B. (2006). Alcohol in Europe. London: Institute of Alcohol Studies
2. Armitage, C., and Conner, M. (2001). Efficacy of the theory of planned behaviour: a meta-analytic review. Br. J. Soc. Psychol. 40, 471-499. doi: 10.1348/014466601164939
3. Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., and Fiore, M. C. (2004). Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol. Rev. 111, 33-51. doi: 10.1037/0033-295X.111.1.33
4. Bauer, D. J., and Curran, P. J. (2004). The integration of continuous and discrete latent variable models: potential problems and promising opportunities. Psychol. Methods 9, 3-29. doi: 10.1037/1082-989X.9.1.3
5. Baumeister, S., Kraus, L., Stonner, T., and Metz, K. (2008). Tabakkonsum, nikotinabhängigkeit und trends. Ergebnisse des epidemiologischen Suchtsurveys 2006. Sucht 54, 26-35. doi: 10.1024/2008.07.04
6. Beauducel, A., and Wittmann, W. W. (2005). Simulation study on fit indexes in CFA based on data with slightly distorted simple structure. Struct. Equ. Modeling 12, 41-75. doi: 10.1207/s15328007sem1201_3
7. Boys, A., Marsden, J., and Strang, J. (2001). Understanding reasons for drug use amongst young people: a functional perspective. Health Educ. Res. 16, 457-469. doi: 10.1093/her/16.4.457
8. Brand, R., and Koch, H. (2016). Using caffeine pills for performance enhancement. An experimental study on university students' willingness and their intention to try neuroenhancements. Front. Psychol. 7:101. doi: 10.3389/fpsyg.2016.00101
9. Brand, R., Wolff, W., and Thieme, D. (2014). Using response-time latencies to measure athletes' doping attitudes: the brief implicit attitude test identifies substance abuse in bodybuilders. Subst. Abuse Treat. Prev. Policy 9:36. doi: 10.1186/1747-597X-9-36
10. Caviola, L., Mannino, A., Savulescu, J., and Faulmuller, N. (2014). Cognitive biases can affect moral intuitions about cognitive enhancement. Front. Syst. Neurosci. 8:195. doi: 10.3389/fnsys.2014.00195
11. Clark, V. P., and Parasuraman, R. (2014). Neuroenhancement: enhancing brain and mind in health and in disease. Neuroimage 85, 889-894. doi: 10.1016/j.neuroimage.2013.08.071
12. Dietz, P., Striegel, H., Franke, A. G., Lieb, K., Simon, P., and Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy 33, 44-50. doi: 10.1002/phar.1166
13. Farah, M. J. (2012). Neuroethics: the ethical, legal, and societal impact of neuroscience. Ann. Rev. Psychol. 63, 571-591. doi: 10.1146/annurev.psych.093008.100438
14. Fond, G., Micoulaud-Franchi, J. A., Macgregor, A., Richieri, R., Miot, S. Lopez, R., et al. (2015). Neuroenhancement in healthy adults, part I: pharmaceutical cognitive enhancement: a systematic review. J. Clin. Res. Bioeth. 6:213. doi: 10.4172/2155-9627.1000213
15. Franke, A. G., Bagusat, C., Rust, S., Engel, A., and Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur. Arch. Psychiatry Clin. Neurosci. 264, 83-90. doi: 10.1007/s00406-014-0537-1
16. Franke, A. G., Christmann, M., Bonertz, C., Fellgiebel, A., Huss, M., and Lieb, K. (2011). Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44, 331-338. doi: 10.1055/s-0031-1286347
17. Glannon, W. (2015). "Reflections on neuroenhancement," in Handbook of Neuroethics, eds J. Clausen and N. Levy (Dordrecht: Springer), 1251-1265
18. Greenberg, B. G., Abul-Ela, A. A., Simmons, W. R., and Horvitz, D. G. (1969). The unrelated question randomized response model: theoretical framework. J. Am. Stat. Assoc. 64, 520-539. doi: 10.1080/01621459.1969.10500991
19. Greenwald, A. G., McGhee, D. E., and Schwartz, J. L. K. (1998). Measuring individual differences in implicit cognition: the implicit association test. J. Pers. Soc. Psychol. 74, 1464-1480. doi: 10.1037/0022-3514.74.6.1464
20. Greenwald, A. G., Poehlman, T. A., Uhlmann, E. L., and Banaji, M. R. (2009). Understanding and using the implicit association test: III. Meta-analysis of predictive validity. J. Pers. Soc. Psychol. 97, 17-41. doi: 10.1037/a0015575
21. Heene, M., Hilbert, S., Draxler, C., Ziegler, M., and Buehner, M. (2011). Masking misfit in confirmatory factor analysis by increasing unique variances: a cautionary note on the usefulness of cutoff values of fit indices. Psychol. Methods 16, 319-336. doi: 10.1037/a0024917
22. Hildt, E., and Franke, A. G. (Eds.). (2013). Cognitive Enhancement: An Interdisciplinary Perspective. New York, NY: Springer
23. Horn, J. L. (1965). A rationale and test for the number of factors in factor analysis. Psychometrika 30, 179-185. doi: 10.1007/BF02289447
24. Hu, L. T., and Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equ. Modeling 6, 1-55. doi: 10.1080/10705519909540118
25. Johnston, L. D., O'Malley, P. M., Bachman, J. G., and Schulenberg, J. E. (2010). Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2009 (NIH Publication No. 10-7583). Bethesda, MD: National Institute on Drug Abuse
26. Kandel, D., Chen, K., Warner, L. A., Kessler, R. C., and Grant, B. (1997). Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the US population. Drug Alcohol Depend. 44, 11-29. doi: 10.1016/S0376-8716(96)01315-4
27. Koob, G. F., and LeMoal, M. (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58. doi: 10.1126/science.278.5335.52
28. Kreuter, M. W., and Wray, R. J. (2003). Tailored and targeted health communication: strategies for enhancing information relevance. Am. J. Health Behav. 27, S227-S232. doi: 10.5993/AJHB.27.1.s3.6
29. Leite, W. L., and Cooper, L. A. (2010). Detecting social desirability bias using factor mixture models. Multivar. Behav. Res. 45, 271-293. doi: 10.1080/00273171003680245
30. Lubke, G. H., and Muthen, B. (2005). Investigating population heterogeneity with factor mixture models. Psychol. Methods 10, 21-39. doi: 10.1037/1082-989X.10.1.21
31. Lubke, G. H., and Muthen, B. O. (2007). Performance of factor mixture models as a function of model size, covariate effects, and class-specific parameters. Struct. Equ. Modeling 14, 26-47. doi: 10.1080/10705510709336735
32. Mache, S., Eickenhorst, P., Vitzthum, K., Klapp, B. F., and Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wien. Med. Wochenschr. 162, 262-271. doi: 10.1007/s10354-012-0115-y
33. Maher, B. (2008). Poll results: look who's doping. Nature 452, 674-675. doi: 10.1038/452674a
34. Maier, L. J., and Schaub, M. P. (2015). The use of prescription drugs and drugs of abuse for neuroenhancement in Europe: not widespread but a reality. Eur. Psychol. 20, 155-166. doi: 10.1027/1016-9040/a000228
35. Maslen, H., Faulmuller, N., and Savulescu, J. (2014). Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Front. Syst. Neurosci. 8:107. doi: 10.3389/fnsys.2014.00107
36. Mazanov, J., Dunn, M., Connor, J., and Fielding, M. L. (2013). Substance use to enhance academic performance among Australian university students. Perform. Enhanc. Health 2, 110-118. doi: 10.1016/j.peh.2013.08.017
37. McCabe, S. E., Knight, J. R., Teter, C. J., and Wechser, H. (2005). Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100, 96-106. doi: 10.1111/j.1360-0443.2005.00944.x
38. Meredith, S. E., Juliano, L. M., Hughes, J. R., and Griffiths, R. R. (2013). Caffeine use disorder: a comprehensive review and research agenda. J. Caffeine Res. 3, 114-130. doi: 10.1089/jcr.2013.0016
39. Middendorff, E., Poskowsky, J., and Becker, K. (2015). Formen der Stresskompensation und Leistungssteigerung bei Studierenden: Wiederholungsbefragung des HISBUS-Panels zu Verbreitung und Mustern studienbezogenen Substanzkonsums. Hannover: DZHW
40. Müller, C. P., and Schumann, G. (2011). Drugs as instruments: a new framework for non-addictive psychoactive drug use. Behav. Brain Sci. 34, 293-310. doi: 10.1017/S0140525X11000057
41. Müller, C. P., and Schumann, G. (2011b). To use or not to use: expanding the view on non-addictive psychoactive drug consumption and its implications. Behav. Brain Sci. 34, 328-347. doi: 10.1017/S0140525X1100135X
42. Muthén Muthén (2013). MPLUS (Version 7). Los Angeles, CA: Muthén & Muthén
43. Neale, C., Camfield, D., Reay, J., Stough, C., and Scholey, A. (2013). Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes. Br. J. Clin. Pharmacol. 75, 728-737. doi: 10.1111/bcp.12002
44. O'Brien, C. P., Childress, A. R., McLellan, A. T., and Ehrman, R. (1992). "A learning model of addiction," in Research Publications: Association for Research in Nervous and Mental Disease, eds C. P. O'Brien and J. H. Jaffe (New York, NY: Raven Press), 157-177
45. Partridge, B. J., Bell, S. K., Lucke, J. C., Yeates, S., and Hall, W. D. (2011). Smart drugs "as common as coffee": media hype about neuroenhancement. PLoS ONE 6:e28416. doi: 10.1371/journal.pone.0028416
46. Rath, M. (2012). Energy drinks: what is all the hype? The dangers of energy drink consumption. J. Am. Acad. Nurse Pract. 24, 70-76. doi: 10.1111/j.1745-7599.2011.00689.x
47. R Development Core Team (2013). R: A Language and Environment for Statistical Computing. Vienna: R Foundation for statistical computing
48. Revelle, W. (2014). Psych: Procedures for Personality and Psychological Research (Version 1.4.5). Evanston, IL: Northwestern University
49. Rimer, B. K., and Kreuter, M. W. (2006). Advancing tailored health communication: a persuasion and message effects perspective. J. Commun. 56, 184-201. doi: 10.1111/j.1460-2466.2006.00289.x
50. Rossel, Y. (2012). lavaan: an r package for structural equation modeling. J. Stat. Softw. 48, 1-36. doi: 10.18637/jss.v048.i02
51. Sattler, S., Mehlkop, G., Graeff, P., and Sauer, C. (2014). Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Subst. Abuse Treat. Prev. Policy 9:8. doi: 10.1186/1747-597X-9-8
52. Smith, M. E., and Farah, M. J. (2011). Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol. Bull. 137, 717-741. doi: 10.1037/a0023825
53. United Nations (2011). The Non-Medical Use of Prescription Drugs. Policy Direction Issues. Vienna: United Nations Office on Drug and Crimes
54. Velicer, W. F. (1976). Determining number of components from matrix of partial correlations. Psychometrika 41, 321-327. doi: 10.1007/BF02293557
55. Walsh, J. K., Muehlbach, M. J., Humm, T. M., Dickins, Q. S., Sugerman, J. L., and Schweitzer, P. K. (1990). Effect of caffeine on physiological sleep tendency and ability to sustain wakefulness at night. Psychopharmacology 101, 271-273. doi: 10.1007/BF02244139
56. Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., et al. (2008). Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Adolesc. Psychiatry 47, 21-31. doi: 10.1097/chi.0b013e31815a56f1
57. Wolff, W., and Brand, R. (2013). Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping." Subst. Abuse Treat. Prev. Policy 8:23. doi: 10.1186/1747-597X-8-23
58. Wolff, W., Brand, R., Baumgarten, F., Lösel, J., and Ziegler, M. (2014). Modeling students' instrumental (mis-)use of substances to enhance cognitive performance: Neuroenhancement in the light of job-demands-resources theory. BioPsychoSocial Med. 8:12. doi: 10.1186/1751-0759-8-12
59. Wolff, W., Sandouqa, Y., and Brand, R. (2016). Using the simple sample count to estimate the frequency of prescription drug neuroenhancement in a sample of Jordan employees. Int. J. Drug Policy 31, 51-55. doi: 10.1016/j.drugpo.2015.12.014
60. Wolff, W., Schindler, S., and Brand, R. (2015). The effect of implicitly incentivized faking on explicit and implicit measures of doping attitude: when athletes want to pretend an even more negative attitude to doping. PLoS ONE 10:e0118507. doi: 10.1371/journal.pone.0118507
61. Zelli, A., Lucidi, F., and Mallia, L. (2015). The complexity of neuroenhancement and the adoption of a social cognitive perspective. Front. Psychol. 6:1880. doi: 10.3389/fpsyg.2015.01880
62. Ziegler, M., and Hagemann, D. (2015). Testing the unidimensionality of items: pitfalls and loopholes. Eur. J. Psychol. Assess. 31, 231-237. doi: 10.1027/1015-5759/a000309
63. Ziegler, M., Maaß, U., Griffith, R., and Gammon, A. (2015). What is the nature of faking? Modeling distinct response patterns and quantitative differences in faking at the same time. Organ. Res. Methods 20, 1-25. doi: 10.1177/1094428115574518
64. Zohny, H. (2015). The myth of cognitive enhancement drugs. Neuroethics 8, 257-269. doi: 10.1007/s12152-015-9232-9